New: NCI-funded clinical trial search
Mednet Logo

Would you offer PMRT for cT2N0 triple negative breast cancer s/p NAC and mastectomy with residual disease and no positive lymph nodes?

Patient will receive adjuvant xeloda.
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

We need more data. For microscopic residual have not been offering it but if there is residual disease more than 2 cm, we would consider the patient for PMRT.

Join for free or sign in to see the full answer